Can a multibillion-dollar biotech prove its RNA drugs are safe for a rare disease?
This $5 Billion Startup Made Its First Cancer Vaccine—For Just One Person
AstraZeneca and Moderna take a big, early step forward in their quest to prove mRNA works in humans
Moderna initiates Chikungunya vaccine human test, replaces backup Zika candidate
Moderna, AstraZeneca heart drug succeeds early-stage trial
Top Novartis manufacturing exec jumps ship, takes charge of industrializing Moderna’s mRNA tech
Moderna brings on former Novartis exec to oversee manufacturing of mRNA therapies
Moderna taps Novartis exec to lead manufacturing blitz
‘Don’t underestimate Merck’s vaccine business,’ says CEO
Meet the 2017 CNBC Disruptor 50 Companies
